| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |